Plan B Headed For Behind-The-Counter Sale
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is understood to have decided to approve the emergency contraceptive as a new, third class of product, which would restrict access but not require a prescription.You may also be interested in...
Plan B Advertising: Barr Has No Plans For Broad DTC Campaign
The company is running ads in college newspapers, but there are no plans for a broader campaign due to uncertainty over whether the emergency contraceptive will be switched over-the-counter.
Plan B Advertising: Barr Has No Plans For Broad DTC Campaign
The company is running ads in college newspapers, but there are no plans for a broader campaign due to uncertainty over whether the emergency contraceptive will be switched over-the-counter.
Crawford FDA Confirmation Vote Expected By Mid-May
The vote would come just over a month after an April 13 Senate Health Committee vote on Crawford's nomination for FDA commissioner was abruptly cancelled. Barr expects FDA approval of its Rx-to-OTC switch application for Plan B once a permanent commissioner is in place.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: